CYTOTECH ApS: Financial statements 2019
CVR: 19898504
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
CYTOTECH ApS (CVR 19898504) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 377,502 and a net result of DKK 149,313 compared with DKK 119,391 the year before. That is an increase of 42% compared with the year before. Equity in the 2019 report amounted to DKK 212,167. The solvency ratio was 53.8%.
- Gross Profit
- DKK 377,502
- Profit/Loss
- DKK 149,313
- Equity
- DKK 212,167
- Total Assets
- DKK 394,336
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | 378 t. | 149 t. | 212 t. | - |
| 2018 | - | 266 t. | 119 t. | 63 t. | - |
| 2017 | - | 270 t. | 49 t. | -57 t. | - |
| 2016 | - | 237 t. | -133 t. | -105 t. | - |
| 2015 | - | 354 t. | 13 t. | 27 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
CYTOTECH ApS has published its annual report for 2018. Gross profit came to DKK 265,895, and the net result was DKK 119,391.
About CYTOTECH ApS
CYTOTECH ApS is a Danish company of the type Anpartsselskab based in Hellebæk, founded in 1997. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The management consists of Patrick van Dijk Munch-Fals. The company is owned by Patrick van Dijk Munch-Fals. The company has 0 employees (2018). In 2025, the company reported a gross profit of DKK 196,108 and a net result of DKK -70,656 compared with DKK -113,059 the year before. Equity in the 2025 report amounted to DKK -27,461.